The GA2LEN chamber has been developed as a novel mobile allergen exposure chamber (AEC) allowing standardized multicenter trials in allergy. Hitherto, subjective nasal symptom scores have been the most often used...
http://ift.tt/2hcQLyM
Αρχειοθήκη ιστολογίου
-
▼
2020
(289)
-
▼
Αυγούστου
(73)
-
▼
Αυγ 27
(17)
- Cancers
- High Altitude Medicine & Biology - Table of Cont...
- Eczema moisturizers: Allergenic Pote
- COVID‐19 und Auswirkungen auf dermatologische und...
- Asymptomatic chyluria presenting with fat-fl
- Evaluation of the Toxicity of Supernatant Culture...
- Biomedicine & Pharmacotherapy
- Dysphagia - Rehabilitation
-
▼
Αυγ 27
(17)
- ► Φεβρουαρίου (28)
-
▼
Αυγούστου
(73)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
►
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Τρίτη 19 Σεπτεμβρίου 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN study
Δευτέρα 18 Σεπτεμβρίου 2017
Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future
Percutaneous skin prick tests (SPT) have been considered the preferred method for confirming IgE-mediated sensitization. This reliable and minimally invasive technique correlates with in vivo challenges, has g...
http://ift.tt/2xcZ3KR
Debates in allergy medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future
In today's clinical practice patients' skin is used as screening organ for diagnosing type 1 allergy. According to European guidelines skin prick testing with a panel of 18 allergen extracts is recommended, in...
http://ift.tt/2yaDf20
Pitted keratolysis – a study of various clinical manifestations
Abstract
Background
Pitted keratolysis (PK) is a common bacterial infection of skin characterized by noninflammatory superficial pits. Very few studies have focused on variations in clinical manifestations of PK. We conducted this study so that diagnosis of this treatable condition is not missed when it presents in an uncommonly perceived way.
Aims and objectives
Assessment of PK patients for various sites and morphologies.
Materials and methods
A total of 30 patients with PK were assessed for various sites and morphologies. Bacterial and fungal cultures along with histopathology were performed.
Results
Of 30 patients, 24 were females. Hyperhidrosis and malodour were the most common symptoms. Interdigital interface skin of the toes was the first site affected in most patients. Plantar skin was affected in all patients with involvement of interface skin of the toes in 29 patients. Other sites affected were palms, finger web spaces, nonglabrous skin, paronychium, and nail. Other than classical pits, scaly crusted inflammatory lesions with post-inflammatory hyperpigmentation (PIH) were noted. Associated keratoderma was also reported in some patients.
Discussion
The presence of hyperhidrosis, malodour, and plantar lesions is consistent with previous studies. Interface skin between toes as the first site affected, involvement of toe web spaces, and associated keratoderma have been reported rarely. However, female preponderance, involvement of finger web spaces, nonglabrous skin, paronychium, nail changes, the presence of inflammation with crusting, and PIH have never been reported previously.
Conclusion
PK can involve web spaces, nonglabrous skin, and paronychium, and can cause nail changes. The lesions can be inflammatory with crusting and PIH.
http://ift.tt/2wrQcbk
Kimura's disease in the oral cavity: A rare manifestation of immunoglobulin G4-related disease
http://ift.tt/2xa4xZm
Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome
Abstract
Angiogenesis is an important step to support progression of malignancies, including mycosis fungoides (MF) and Sézary syndrome (SS). Vascular endothelial growth factor (VEGF)-A, a key player in angiogenesis, is secreted by tumor cells of MF/SS and its expression levels in lesional skin correlated with disease severity. In this study, we examined serum VEGF-A levels in MF/SS patients. Serum VEGF-A levels were elevated in patients with erythrodermic MF/SS and the levels decreased after treatment. Importantly, serum VEGF-A levels positively correlated with markers for pruritus. We also found that VEGF-A upregulated mRNA expression of thymic stromal lymphopoietin by keratinocytes. Taken together, our study suggests that VEGF-A can promote progression and pruritus in MF/SS. Inhibition of VEGF-A signaling can be a therapeutic strategy for patients with erythrodermic MF/SS.
http://ift.tt/2fwyfgY